Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 1 (January)

1. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
   J Clin Virol, 35(1): 21-5. [Abstract] [Full-text]
2. Designing antibodies for oncology.
   Cancer Metastasis Rev, 24(4): 585-98. [Abstract] [Full-text]
3. The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
   Cancer, 106(2): 297-303. [Abstract] [Full-text]
4. Molecular approaches in pediatric oncology.
   Annu Rev Med, 57: 83-97. [Abstract] [Full-text]
5. Advances in radiation oncology.
   Annu Rev Med, 57: 19-31. [Abstract] [Full-text]
6. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
   Gynecol Oncol, 100(2): 385-8. [Abstract] [Full-text]
7. Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group.
   Pediatr Blood Cancer, 46(3): 329-38. [Abstract] [Full-text]
8. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
   Gynecol Oncol, 100(2): 349-54. [Abstract] [Full-text]
9. APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.
   Pediatr Blood Cancer, 46(3): 320-4. [Abstract] [Full-text]
10. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
    Int J Radiat Oncol Biol Phys, 64(2): 408-13. [Abstract] [Full-text]
11. Standards of nutritional care in pediatric oncology: results from a nationwide survey on the standards of practice in pediatric oncology. A Children's Oncology Group study.
    Pediatr Blood Cancer, 46(3): 339-44. [Abstract] [Full-text]
12. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy.
    Infect Control Hosp Epidemiol, 27(1): 92-5. [Abstract] [Full-text]
13. Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality.
    Support Care Cancer, 14(2): 147-52. [Abstract] [Full-text]
14. Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology.
    Support Care Cancer, 14(1): 91-7. [Abstract] [Full-text]
15. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
    Support Care Cancer, 14(2): 172-6. [Abstract] [Full-text]
16. Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer.
    Ann Surg Oncol, 13(1): 86-95. [Abstract] [Full-text]
17. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.
    J Clin Oncol, 24(3): 431-6. [Abstract] [Full-text]
18. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
    Clin Cancer Res, 12(2): 516-22. [Abstract] [Full-text]
19. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires.
    J Clin Epidemiol, 59(2): 185-91. [Abstract] [Full-text]
20. Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone-a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO).
    J Cancer Res Clin Oncol, 132(4): 205-12. [Abstract] [Full-text]
21. Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study.
    Invest New Drugs. [Abstract] [Full-text]
22. The Wnt-dependent signaling pathways as target in oncology drug discovery.
    Invest New Drugs. [Abstract] [Full-text]
23. A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
    Int J Hematol, 83(1): 55-62. [Abstract] [Full-text]
24. Fertility preservation in female oncology patients.
    Aust N Z J Obstet Gynaecol, 46(1): 15-23. [Abstract] [Full-text]
25. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
    J Clin Oncol, 24(4): 650-5. [Abstract] [Full-text]
26. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
    J Clin Oncol, 24(4): 619-25. [Abstract] [Full-text]
27. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 24(4): 587-92. [Abstract] [Full-text]
28. Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study.
    Int J Gynecol Cancer, 16(1): 298-305. [Abstract] [Full-text]
29. Difficult clinical decisions in gynecological oncology: identifying priorities for future clinical research.
    Int J Gynecol Cancer, 16(1): 1-7. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.